688016 心脉医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)7.73714.32113.15117.70522.215
总资产报酬率 ROA (%)6.71712.61311.76215.78019.040
投入资产回报率 ROIC (%)7.54513.99212.90217.40721.507

边际利润分析
销售毛利率 (%)71.35571.08273.01176.45175.180
营业利润率 (%)47.48848.42254.80948.33746.315
息税前利润/营业总收入 (%)48.16948.07752.68447.49444.950
净利润/营业总收入 (%)39.99241.06740.84741.03939.269

收益指标分析
经营活动净收益/利润总额(%)95.29890.91783.24295.39993.997
价值变动净收益/利润总额(%)1.7062.50113.4031.5990.991
营业外收支净额/利润总额(%)-0.064-0.079-1.377-0.277-0.319

偿债能力分析
流动比率 (X)5.4176.8478.08210.7606.928
速动比率 (X)4.8666.1817.29610.0856.093
资产负债率 (%)13.72311.69210.9319.01112.656
带息债务/全部投入资本 (%)0.075-1.231-0.710-0.634-0.884
股东权益/带息债务 (%)129,241.585-7,963.362-13,718.529-15,596.055-10,993.699
股东权益/负债合计 (%)625.912751.033808.2791,004.566680.676
利息保障倍数 (X)67.733-156.814-38.175-67.016-36.910

营运能力分析
应收账款周转天数 (天)93.23877.01053.39741.25239.592
存货周转天数 (天)228.210248.266263.874236.194212.663